Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01809925 · ClinicalTrials.gov registry record · NA
Study of Psyllium 6.8 g Versus Placebo on Satiety in Healthy Volunteers
A NA study of Hunger, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT01809925: Completed NA study of Hunger, sponsored by Procter and Gamble.
NCT01809925 is a NA study of Hunger that has completed, run by Procter and Gamble. The registered enrollment target is 45 participants, below the 80-participant average among 7 other Hunger trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01809925, a NA study of Hunger, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double-blind, placebo-controlled, 2-treatment, 3-period crossover design study to evaluate the effects of psyllium 6.8 g provided as sugarfree Metamucil fiber supplement powder dissolved in water versus placebo on satiety measures in healthy volunteers. This study will be conducted at a single study site.
Primary Outcome
VAS Hunger 3-day average. This endpoint will be calculated by averaging all evaluable post-breakfast scores across Days 1, 2, and 3. VAS Hunger is assessed on a horizontal 100-mm VAS anchored on the left by the phrase "Not at all hungry" (score = 0) and on the right by "As hungry as I have ever felt" (score = 100).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT psyllium fiber 6.8g
Study Locations (1)
Ohio
- Study Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT01809925 record still lists
NCT01809925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 80-participant average among 7 other Hunger trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Hunger appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01809925 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01809925 about?
NCT01809925 is a clinical study titled "Study of Psyllium 6.8 g Versus Placebo on Satiety in Healthy Volunteers". This is a randomized, double-blind, placebo-controlled, 2-treatment, 3-period crossover design study to evaluate the effects of psyllium 6.8 g provided as sugarfree Metamucil fiber supplement powder dissolved in water versus placebo on satiety measures in healthy volunteers. This study will be condu...
What is the current status of trial NCT01809925?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2013-03. Estimated completion is 2013-04.
What conditions does trial NCT01809925 study?
This clinical trial studies the following conditions: Hunger.
What interventions are being tested in trial NCT01809925?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), psyllium fiber 6.8g (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01809925?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01809925 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hunger
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement
RECRUITING · NA
-
Food Orders on Blood Glucose and Fuel Use At Rest
RECRUITING · NA
-
Maximizing Nutrition Education to Meet Dietary and Food Security of Children and Parents
RECRUITING · NA
-
Barley and Rice Mixture Effects on Blood Glucose
COMPLETED · NA
-
The Effect of Television Watching on Liking of Food
COMPLETED · NA
-
The Breakfast Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia